These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2169852)

  • 1. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer; 1990 Sep; 62(3):410-4. PubMed ID: 2169852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.
    Derbyshire EJ; de Leij L; Wawrzynczak EJ
    Br J Cancer; 1993 Jun; 67(6):1242-7. PubMed ID: 8390281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.
    Derbyshire EJ; Stahel RA; Wawrzynczak EJ
    Cancer Immunol Immunother; 1992; 35(6):417-20. PubMed ID: 1327529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
    Derbyshire EJ; Henry RV; Stahel RA; Wawrzynczak EJ
    Br J Cancer; 1992 Sep; 66(3):444-51. PubMed ID: 1325825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.
    Derbyshire EJ; Wawrzynczak EJ
    Br J Cancer Suppl; 1991 Jun; 14():74-7. PubMed ID: 1645578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
    Derbyshire EJ; Wawrzynczak EJ
    Int J Cancer; 1992 Oct; 52(4):624-30. PubMed ID: 1328073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
    Zangemeister-Wittke U; Collinson AR; Fisch I; Jones RM; Waibel R; Lehman HP; Stahel RA
    Int J Cancer; 1993 Jul; 54(6):1028-35. PubMed ID: 8392978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.
    Wawrzynczak EJ; Zangemeister-Wittke U; Waibel R; Henry RV; Parnell GD; Cumber AJ; Jones M; Stahel RA
    Br J Cancer; 1992 Aug; 66(2):361-6. PubMed ID: 1323991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID mice.
    Schnell R; Katouzi AA; Linnartz C; Schoen G; Drillich S; Hansmann ML; Schiefer D; Barth S; Zangemeister-Wittke U; Stahel RA; Diehl V; Engert A
    Int J Cancer; 1996 May; 66(4):526-31. PubMed ID: 8635869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.
    Zangemeister-Wittke U; Collinson AR; Frösch B; Waibel R; Schenker T; Stahel RA
    Br J Cancer; 1994 Jan; 69(1):32-9. PubMed ID: 7506925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.
    Roy DC; Ouellet S; Le Houillier C; Ariniello PD; Perreault C; Lambert JM
    J Natl Cancer Inst; 1996 Aug; 88(16):1136-45. PubMed ID: 8757193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
    Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
    Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells.
    Levin LV; Griffin TW; Childs LR; Davis S; Haagensen DE
    Cancer Immunol Immunother; 1987; 24(3):202-6. PubMed ID: 3496151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of a CD24-specific deglycosylated ricin-A-chain immunotoxin in conventional and novel models of small-cell-lung-cancer xenograft.
    Zangemeister-Wittke U; Lehmann HP; Waibel R; Wawrzynczak EJ; Stahel RA
    Int J Cancer; 1993 Feb; 53(3):521-8. PubMed ID: 8381397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
    Recht LD; Griffin TW; Raso V; Salimi AR
    Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins.
    Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ
    Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.
    Till M; May RD; Uhr JW; Thorpe PE; Vitetta ES
    Cancer Res; 1988 Mar; 48(5):1119-23. PubMed ID: 3257712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
    Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.